BYAH
Park Ha Biological Technology Co., Ltd. Ordinary Shares
NASDAQ · Consumer Cyclical · Personal Products & Services · CN
$2.52
−4.55%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.8M | 2.5M | 2.4M | 2.5M | 1.9M |
| Cost of Revenue | 383.8K | 142.5K | 195.3K | 311.0K | 509.2K |
| Gross Profit | 3.4M | 2.4M | 2.2M | 2.1M | 1.4M |
| Operating Expenses | |||||
| R&D Expense | 526.1K | 238.2K | 36.7K | 30.9K | 60.7K |
| SG&A Expense | 11.0M | 26.1M | 1.2M | 784.6K | 1.1M |
| General & Admin Expense | 3.3M | 25.5M | 814.9K | 485.0K | 707.5K |
| Selling & Marketing Expense | 478.0K | 625.3K | 361.3K | 299.6K | 438.6K |
| Other Expenses | — | 184.2K | 179.9K | 152.1K | 6.4K |
| Total Operating Expenses | 11.5M | 26.5M | 1.4M | 967.6K | 1.2M |
| Cost and Expenses | 11.9M | 26.7M | 1.6M | 1.3M | 1.7M |
| Operating Income (EBIT) | (8.1M) | (24.1M) | 793.7K | 1.2M | 197.0K |
| Non-Operating | |||||
| Interest Income | 82.7K | 6.1K | 783.00 | 1.6K | 263.00 |
| Interest Expense | 25.00 | 41.00 | — | — | 194.00 |
| Net Interest Income | 82.7K | 6.1K | 783.00 | 1.6K | 69.00 |
| Other Non-Op Income/Expense | 58.9K | 64.8K | (293.00) | 1.0K | (7.0K) |
| Non-Operating Income (excl Interest) | (6.3K) | (64.8K) | 293.00 | (1.0K) | 6.8K |
| EBT (Pre-Tax Income) | (8.0M) | (24.1M) | 793.4K | 1.2M | 190.0K |
| Income Tax Expense | 135.7K | 280.6K | 314.9K | 329.5K | (1.3K) |
| Bottom Line | |||||
| Net Income | (8.2M) | (24.4M) | 478.6K | 852.0K | 191.3K |
| Earnings from Cont. Ops | (8.2M) | (24.4M) | 478.6K | 852.0K | 191.3K |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (8.2M) | (24.4M) | 478.6K | 852.0K | 191.3K |
| Per Share | |||||
| Basic EPS | ($92.00) | ($331.04) | $7.32 | $13.00 | $2.92 |
| Diluted EPS | ($92.00) | ($331.04) | $7.32 | $13.00 | $2.92 |
| Revenue Per Share | $6.20 | $34.30 | $36.36 | $37.54 | $29.30 |
| Shares | |||||
| Basic Shares Outstanding | 615610 | 73608 | 65500 | 65500 | 65500 |
| Diluted Shares Outstanding | 615610 | 73608 | 65500 | 65500 | 65500 |
| Profitability Metrics | |||||
| EBITDA | (7.8M) | (24.0M) | 816.1K | 1.2M | 220.7K |
| D&A | 283.7K | 109.4K | 22.7K | 20.1K | 30.5K |
| EBIT | (8.1M) | (24.1M) | 793.4K | 1.2M | 190.2K |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Apr 1, 2026